These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3839479)

  • 1. Effect of peptide YY on gastric, pancreatic, and biliary function in humans.
    Adrian TE; Savage AP; Sagor GR; Allen JM; Bacarese-Hamilton AJ; Tatemoto K; Polak JM; Bloom SR
    Gastroenterology; 1985 Sep; 89(3):494-9. PubMed ID: 3839479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraluminal peptide YY on pancreatic function.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    Int J Pancreatol; 1992 Oct; 12(2):153-60. PubMed ID: 1460330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY: metabolism and effect on pancreatic secretion in dogs.
    Pappas TN; Debas HT; Taylor IL
    Gastroenterology; 1985 Dec; 89(6):1387-92. PubMed ID: 3840443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY interacts with secretin and duodenal acidification to inhibit gastric acid secretion.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Townsend CM; Thompson JC
    Regul Pept; 1987 Aug; 18(3-4):155-63. PubMed ID: 3671783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.
    Wettergren A; Maina P; Boesby S; Holst JJ
    Scand J Gastroenterol; 1997 Jun; 32(6):552-5. PubMed ID: 9200286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of peptide YY on pancreatico-biliary secretion in humans.
    Symersky T; Biemond I; Frolich M; Masclee A
    Scand J Gastroenterol; 2005 Aug; 40(8):944-9. PubMed ID: 16173137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide.
    Playford RJ; Benito-Orfila MA; Nihoyannopoulos P; Nandha KA; Cockcroft J; Todd S; Ghatei MA; Domin J; Bloom SR; Calam J
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E740-7. PubMed ID: 1415694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of unstimulated exocrine pancreatic secretion by peptide YY in the rat.
    Robinson DC; Rudnicki M; Tito JM; Gold MS
    World J Surg; 1996 Feb; 20(2):208-14. PubMed ID: 8661819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers.
    Savage AP; Adrian TE; Carolan G; Chatterjee VK; Bloom SR
    Gut; 1987 Feb; 28(2):166-70. PubMed ID: 3557189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion.
    Pappas TN; Debas HT; Goto Y; Taylor IL
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G118-23. PubMed ID: 3838121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterogastrone-like effect of peptide YY is vagally mediated in the dog.
    Pappas TN; Debas HT; Taylor IL
    J Clin Invest; 1986 Jan; 77(1):49-53. PubMed ID: 2868024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
    Eissele R; Koop H; Arnold R
    Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of peptide YY in regulation of duodenal motility during the interdigestive period in sheep.
    Onaga T; Kubagawa S; Lee S; Mineo H; Kato S; Naruse S; Ozaki T
    J Comp Physiol B; 1997 Jul; 167(5):352-60. PubMed ID: 9265747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory action of peptide YY on pancreatic secretion is independent of secretin.
    Lluis F; Gomez G; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):88-93. PubMed ID: 1307917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on the interrelationship between organs mediated by peptide YY: effect on splanchnic circulation and exocrine pancreas in dogs.
    Sumi S; Inoue K; Tobe T
    Nihon Geka Hokan; 1990 May; 59(3):224-33. PubMed ID: 2130785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide YY inhibits pancreatic secretion by inhibiting cholecystokinin release in the dog.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
    Gastroenterology; 1988 Jan; 94(1):137-44. PubMed ID: 3335285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human gastric acid secretion by peptide YY and secretin.
    Olsen O; Christiansen J
    Digestion; 1990; 47(3):156-9. PubMed ID: 2083801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man.
    Adrian TE; Sagor GR; Savage AP; Bacarese-Hamilton AJ; Hall GM; Bloom SR
    J Clin Endocrinol Metab; 1986 Oct; 63(4):803-7. PubMed ID: 3755728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs.
    Pappas TN; Debas HT; Chang AM; Taylor IL
    Gastroenterology; 1986 Dec; 91(6):1386-9. PubMed ID: 3770364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.